http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100210472-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2b9d16cc05e8ba6f652a3d132a15336 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
| filingDate | 1992-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c52dc341213f564e3c0978af1262643 |
| publicationDate | 1999-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100210472-B1 |
| titleOfInvention | Progesterone Hormone Secretion Hormone Antagonist Peptide |
| abstract | Progesterone secreting hormone antagonist peptides are provided that effectively reduce the plasma concentrations of estrogen and androgen. This peptide exhibits increased levels of efficacy while minimizing histamine secretion properties, vascular permeability (or edema effect), hypotension, low water solubility and inappropriate delay of response associated with past luteinizing hormone secretory hormone antagonist peptides. |
| priorityDate | 1991-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.